Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Teradata Corp
TDC
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
eBay
EBAY
US Stock MarketDetailed Quotes
EHAB Enhabit
- 7.710
- -0.220-2.77%
Trading Dec 19 10:20 ET
387.69MMarket Cap-3.31P/E (TTM)
8.010High7.710Low42.27KVolume8.005Open7.930Pre Close330.15KTurnover0.11%Turnover RatioLossP/E (Static)50.28MShares11.74052wk High0.68P/B308.70MFloat Cap6.85052wk Low--Dividend TTM40.04MShs Float25.250Historical High--Div YieldTTM3.78%Amplitude6.850Historical Low7.810Avg Price1Lot Size
Enhabit Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 350.79%28.4M | 0.00%9.6M | -41.55%17.3M | -39.58%48.4M | -29.27%2.9M | 530.00%6.3M | -71.43%9.6M | -28.50%29.6M | -35.04%80.1M | -82.25%4.1M |
| Net income from continuing operations | -4,877.27%-109.5M | 100.54%400K | -71.88%900K | -106.27%-79M | 93.77%-5.9M | -124.72%-2.2M | -456.25%-74.1M | -88.01%3.2M | -133.92%-38.3M | -417.79%-94.7M |
| Depreciation and amortization | 6.49%8.2M | -1.30%7.6M | 0.00%7.8M | -6.36%30.9M | -7.23%7.7M | -3.75%7.7M | -6.10%7.7M | -8.24%7.8M | -10.57%33M | -7.78%8.3M |
| Deferred tax | 157.14%1.2M | 94.69%-600K | -266.67%-500K | -169.77%-11.6M | 183.33%1.5M | -90.91%-2.1M | -841.67%-11.3M | 250.00%300K | -150.00%-4.3M | -123.08%-1.8M |
| Other non cash items | -166.67%-200K | -54.55%500K | -66.67%100K | 142.86%1.7M | --0 | -66.67%300K | 375.00%1.1M | 250.00%300K | 112.50%700K | 113.33%400K |
| Change In working capital | 3,500.00%17M | 77.27%-500K | -56.36%7.2M | 140.07%11.7M | 89.06%-2.1M | 97.54%-500K | -144.00%-2.2M | 211.32%16.5M | 10.98%-29.2M | 11.52%-19.2M |
| -Change in receivables | 176.65%15.1M | -2.33%8.4M | -44.78%-9.7M | -167.59%-14.6M | -38.46%3.2M | -756.67%-19.7M | -36.30%8.6M | -6,600.00%-6.7M | 187.10%21.6M | 477.78%5.2M |
| -Change in prepaid assets | --0 | 100.00%2.2M | -79.56%3.7M | 169.45%19.1M | 84.00%-800K | 103.54%700K | 200.00%1.1M | 1,231.25%18.1M | -27,400.00%-27.5M | -5,100.00%-5M |
| -Change in payables and accrued expense | -25.00%12.3M | 13.46%-13.5M | -16.55%12.1M | 122.08%6.8M | 68.86%-8.5M | 284.27%16.4M | -305.26%-15.6M | 759.09%14.5M | -266.67%-30.8M | -26.98%-27.3M |
| -Change in other current liabilities | -595.24%-10.4M | -35.14%2.4M | 111.70%1.1M | -94.67%400K | -49.37%4M | -61.11%2.1M | 124.67%3.7M | -202.17%-9.4M | 1,400.00%7.5M | 758.33%7.9M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 350.79%28.4M | 0.00%9.6M | -41.55%17.3M | -39.58%48.4M | -29.27%2.9M | 530.00%6.3M | -71.43%9.6M | -28.50%29.6M | -35.04%80.1M | -82.25%4.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 77.78%-400K | 25.00%-600K | 65.63%-1.1M | 87.47%-5.3M | 101.31%500K | -200.00%-1.8M | 61.90%-800K | -128.57%-3.2M | 64.51%-42.3M | -95.90%-38.2M |
| Net PPE purchase and sale | 63.16%-700K | 36.36%-700K | -200.00%-1.8M | 50.70%-3.5M | 105.56%100K | -137.50%-1.9M | 50.00%-1.1M | 73.91%-600K | -65.12%-7.1M | -350.00%-1.8M |
| Net business purchase and sale | --0 | --0 | --0 | 92.29%-2.8M | --0 | --0 | --0 | ---2.8M | 69.11%-36.3M | -83.33%-36.3M |
| Net other investing changes | 200.00%300K | -66.67%100K | 250.00%700K | -9.09%1M | 500.00%400K | -50.00%100K | 200.00%300K | -77.78%200K | -57.69%1.1M | -114.29%-100K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 77.78%-400K | 25.00%-600K | 65.63%-1.1M | 87.47%-5.3M | 101.31%500K | -200.00%-1.8M | 61.90%-800K | -128.57%-3.2M | 64.51%-42.3M | -95.90%-38.2M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -86.21%-10.8M | -52.94%-18.2M | 52.86%-6.6M | -117.74%-40.5M | -165.67%-8.8M | 6.45%-5.8M | -1,290.00%-11.9M | 47.76%-14M | 48.48%-18.6M | 149.63%13.4M |
| Net issuance payments of debt | -100.00%-10M | -55.56%-14M | 45.45%-6M | -105.81%-33.4M | -160.00%-8.4M | 16.67%-5M | -101.58%-9M | -685.71%-11M | 8,086.11%575M | 975.00%14M |
| Cash dividends paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -324.98%-654.9M | --0 |
| Net other financing activities | 0.00%-800K | -44.83%-4.2M | 80.00%-600K | -111.58%-7.1M | 33.33%-400K | -300.00%-800K | -109.15%-2.9M | -109.87%-3M | -51.04%61.3M | -101.71%-600K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -86.21%-10.8M | -52.94%-18.2M | 52.86%-6.6M | -117.74%-40.5M | -165.67%-8.8M | 6.45%-5.8M | -1,290.00%-11.9M | 47.76%-14M | 48.48%-18.6M | 149.63%13.4M |
| Net cash flow | ||||||||||
| Beginning cash position | -17.26%30.2M | -0.51%39.4M | 9.56%29.8M | 240.00%27.2M | -26.51%35.2M | -32.03%36.5M | 86.79%39.6M | 240.00%27.2M | -80.00%8M | 52.55%47.9M |
| Current changes in cash | 1,423.08%17.2M | -196.77%-9.2M | -22.58%9.6M | -86.46%2.6M | 73.91%-5.4M | 77.59%-1.3M | -109.54%-3.1M | -6.06%12.4M | 160.00%19.2M | 11.54%-20.7M |
| End cash Position | 34.66%47.4M | -17.26%30.2M | -0.51%39.4M | 9.56%29.8M | 9.56%29.8M | -26.51%35.2M | -32.03%36.5M | 86.79%39.6M | 240.00%27.2M | 240.00%27.2M |
| Free cash flow | 529.55%27.7M | 4.71%8.9M | -46.55%15.5M | -38.49%44.9M | 30.43%3M | 2,100.00%4.4M | -72.93%8.5M | -25.83%29M | -38.66%73M | -89.87%2.3M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |